Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences

Annals of Oncology : Official Journal of the European Society for Medical Oncology
C I RipamontiE Bruera

Abstract

Oral methadone is considered to be a valid opioid analgesic alternative to morphine and hydromorphone in treating cancer pain. However, the use of methadone could be complicated by the limited knowledge of the equianalgesic dose/ratio with the other analgesic opioids when switching in tolerant patients. In two Palliative Care Units, data collected regarding 88 advanced cancer patients with pain switched from different opioids to oral methadone were reviewed and compared with the aim of determining the equianalgesic dose ratio in relation to the dose of opioid previously administered. The results of this retrospective study suggest that: (1) methadone is much more potent than previously described in literature, (2) the dose ratio between hydromorphone and methadone is higher than as suggested by equianalgesic tables, and (3) the ratio correlates with total opioid dose administered before switching. The fact that methadone ratio is different according to the opioid dose used previously should be taken into careful consideration by the clinician in order to avoid severe toxicity or death during switchover. Prospective studies should be carried out in order to better define our findings.

Citations

Jul 4, 2001·Drugs·C Ripamonti, E D Dickerson
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eduardo BrueraMichael J Fisch
May 3, 2007·Journal of Palliative Medicine·Jack P McNulty
Jul 11, 2000·Current Opinion in Oncology·I ManciniJ J Body
Jul 17, 2004·British Journal of Clinical Pharmacology·Ola DaleEvan D Kharasch
Jan 27, 2007·Current Oncology Reports·John BrysonCamilla Zimmermann
May 25, 2005·The American Journal of Hospice & Palliative Care·Luiz Guilherme L Soares
Feb 15, 2007·The Annals of Pharmacotherapy·Asad E PatanwalaBrian L Erstad
May 27, 2008·Palliative & Supportive Care·Lauren ShaiovaEugene Perlov
Jul 3, 2009·International Journal of Clinical Practice·W Leppert
Oct 22, 2013·The Cochrane Database of Systematic Reviews·Columba Quigley
Jun 6, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Lawrence D JacksonDebbie Selby
Feb 13, 2002·Journal of Palliative Medicine·Eduardo Bruera, Catherine Sweeney
Dec 7, 2006·Pain Practice : the Official Journal of World Institute of Pain·S K ReddyN Gouondraj
Jun 18, 2010·The American Journal of Hospice & Palliative Care·Ashley B PollockSteven J Baumrucker
Feb 24, 2019·The Oncologist·Ashwin ViswanathanEduardo Bruera
Apr 16, 2019·The Clinical Journal of Pain·Myron YasterConstance L Monitto
Oct 4, 2002·The New England Journal of Medicine·Charles B Berde, Navil F Sethna
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S MercadanteL Calderone
Nov 5, 2008·Journal of Palliative Medicine·Paul W WalkerEduardo Bruera
Mar 1, 2012·European Journal of Clinical Pharmacology·Kristin MoksnesOla Dale
Feb 23, 2012·Journal of Palliative Medicine·Sebastiano Mercadante, Eduardo Bruera
Jun 21, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Douglas J Weschules, Kevin T Bain
Jul 13, 2005·Pediatric Clinics of North America·Christine Greco, Charles Berde
Sep 9, 2009·Journal of Pain and Symptom Management·Helena KnotkovaRussell K Portenoy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.